Skip to main content
. 2017 Feb 20;2(4):634–644. doi: 10.1016/j.ekir.2017.01.016

Figure 1.

Figure 1

Single-dose study. Etelcalcetide was injected via the venous blood line after dialysis in hemodialysis patients with secondary hyperparathyroidism (SHPT). (a) Mean (+SD) plasma concentration of etelcalcetide following single-dose i.v. injection. (Inset) First 65 hours of the plasma concentration curve. (b) Percent changes in serum intact parathyroid hormone (iPTH) after single-dose i.v. injection. Data are expressed as mean ± SD. (c) Percent changes in serum albumin-corrected calcium (cCa) after single-dose i.v. injection. Data are expressed as mean ± SD.